里克斯称全球仅约3%、美国约10%的符合条件患者接受肥胖症治疗,市场扩张空间巨大。
“归根结底,空间可能大得多。目前全球范围内,我们估计只有约 3% 的符合条件的患者获得肥胖症治疗,在美国可能约为 10%。所以这个市场的扩张空间是巨大的。”原文 (en)
"It could be a lot more is the bottom line," Ricks said on "Squawk on the Street." "Today, globally, we'd estimate maybe 3% of eligible patients access obesity care. In the U.S., maybe 10%. So the room for expansion here, of this market, is dramatic.